We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




New Treatment Offers Chronic Back Pain Relief

By HospiMedica staff writers
Posted on 04 Jun 2007
A new study has found that a treatment known as pulsed radiofrequency (PRF) is a useful alternative in treating chronic back pain.

Researchers at the Hospital Universitario Puerta de Hierro (Madrid, Spain) conducted a retrospective analysis of 54 consecutive patients who underwent 75 PRF procedures applied to the lumbar dorsal root ganglion (DRG). More...
The patients were divided into three groups according to the etiology of the lesion: herniated disc, spinal stenosis, and failed back surgery syndrome. The analgesic efficacy of the technique was assessed using a 10-point Numeric Rating Scale (NRS) at baseline, and along with the Global Perceived Effect (GPE), at 30, 60, 90, and 180 days. Since PRF does not involve drugs, it may be repeated multiple times.

The researchers found that PRF yielded significant improvements for herniated disc patients and notable improvements for those with spinal stenosis, but not in those with failed back surgery syndrome. The GPE scores confirmed these finding. No complications were noted. This study was published in the March 2007 issue of Pain Practice.

Radiofrequency (RF) thermolesioning is a widespread treatment for chronic back pain, but because of its neurodestructive nature, it is often considered an unsuitable treatment. Additionally, preexisting conditions that accompany chronic back pain, such as neurologic lesions or neuropathic pain contribute in making conventional RF a controversial treatment.

"The use of PRF could reduce or potentially even eliminate these risks, providing safe, effective pain relief for patients with a variety of lower back pain conditions,” said lead author David Abejón M.D.


Related Links:
Hospital Universitario Puerta de Hierro

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mobile X-Ray System
K4W
Head Rest
Medifa 61114_3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.